Universal Access to On-Demand Treatment of Patients with Hereditary Angioedema, the Chilean Experience.In Chile, patients with hereditary angioedema (HAE) type I and type II are protected under Ley Ricarte Soto (LRS), which guarantees access to on demand plasma-derived C1-INH (pdC1-INH) since 2018. 
Ley Ricarte Soto
Universal Access to On-Demand Treatment of Patients with Hereditary Angioedema, the Chilean Experience.In Chile, patients with hereditary angioedema (HAE) type I and type II are protected under Ley Ricarte Soto (LRS), which guarantees access to on demand plasma-derived C1-INH (pdC1-INH) since 2018.  Long-term prophylactic medications should be included in LRS to treat patients with high attack rates and control the costs of frequent on-demand treatment with pdC1-INH.
pdC1-INH